June 9 (Reuters) – Privately held Element Biosciences said on Tuesday it had raised funds in an upsized Series E round, including $175 million from longtime investor Samsung Electronics, to expand
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Shares, bonds bounce as oil skid offers inflation relief
By Wayne Cole SYDNEY, July 27 (Reuters) - Share markets rallied in Asia on Monday…
Pogacar joins cycling greats with fifth Tour victory
VIDEO SHOWS: ARCHIVE MATERIAL OF TADEJ POGACAR AND THE FOUR, FIVE-TIME WINNERS OF THE TOUR…
UPDATE 3-MLB Red Sox vs Blue Jays Box Score
Red Sox 6, Blue Jays 1 Blue Jays ab r h rbi bb so avg…
